Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori
- 1 May 2005
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (5) , 385-391
- https://doi.org/10.1016/j.ijantimicag.2005.01.017
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Helicobacter pylori persistence: biology and diseaseJournal of Clinical Investigation, 2004
- In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain ShirotaApplied and Environmental Microbiology, 2004
- The role of probiotics in the treatment and prevention of Helicobacter pylori infectionInternational Journal of Antimicrobial Agents, 2003
- Natural history and epidemiology ofHelicobacter pyloriinfectionAlimentary Pharmacology & Therapeutics, 2002
- Probiotics: an overview of beneficial effectsAntonie van Leeuwenhoek, 2002
- Community acquired acute Helicobacter pylori gastritisJournal of Gastroenterology and Hepatology, 2000
- Characterization and Antimicrobial Spectrum of Bifidocin B, a Bacteriocin Produced by Bifidobacterium bifidum NCFB 1454Journal of Food Protection, 1998
- Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A modelGastroenterology, 1997
- Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strainsAntimicrobial Agents and Chemotherapy, 1997
- Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.Gut, 1994